Selank dosage: reported doses and schedule
A Russian nasal anxiety peptide with uncertain long-term benefit and safety.
Also called: Селанк, TP-7, Tuftsin-PGP, TKPRPGP.
Nootropic peptides · Tuftsin-derived peptide studied for anxiety and cognition.
Typical reported dose: Two drops in each nostril, three times a day
- Early study: one test dose: 900 mcg intranasally once single test dose, nasal spray. Studied in a trial. Studied in: Adults with psychogenic anxiety. (source)
- Anxiety study: 2700 mcg/day: 2700 mcg/day intranasally daily total; within-day split not stated, nasal spray. Studied in a trial. Studied in: Adults with generalized anxiety disorder. (source)
- Older-adult pilot: three daily doses: 2700 mcg/day as 900 mcg three times daily daily total in three equal administrations, nasal spray. Studied in a trial. Studied in: Adults over 50 with vascular cognitive symptoms. (source)
- Anxiety comparison: 2.7 mg/day: 2700 mcg/day for 14 days daily total; within-day split not specified, nasal spray. Studied in a trial. Studied in: Adults with anxiety-spectrum disorders. (source)
- Selank added to phenazepam: 2700 mcg/day on days 1–14 with phenazepam, then Days 15–21: 20/40 continued; the other 20 stopped daily total; within-day split not specified, nasal spray. Studied in a trial. Studied in: Adults with anxiety-spectrum disorders. (source)
- Parkinson/tremor pilot: three weeks: 1350 mcg/day intranasally daily total; within-day split not stated, nasal spray. Studied in a trial. Studied in: Adults with Parkinson disease or essential tremor. (source)
These are doses reported in labels, trials or user reports, not a personal plan. Check the source behind each one.
Related to Selank
- Semax: A Russian nasal peptide with limited human evidence for brain and nerve effects.
- PE-22-28: An experimental mood peptide studied in mice, with no human trials found.
- Dihexa: An experimental memory compound with disputed animal research and no established human dose.
- P21: An experimental memory peptide with animal research and no established human dose or safety profile.
- Cerebrolysin: An injectable pig brain mixture with mixed stroke, brain-injury and dementia evidence.
Sources
- 503B Bulk Drug Substances List, FDA · FDA · 2026
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act, FDA · FDA · 2026
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks, FDA · FDA · 2026
- MHRA Products | Home, MHRA · MHRA · 2026
- The Prohibited List, World Anti-Doping Agency · World Anti-Doping Agency · 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026, Australian Government · Australian Government · 2026
- Think twice before injecting peptides bought online: unauthorized products can seriously harm you, Health Canada · Health Canada · 2026
- Anaphylaxis, NHS · NHS · 2023
- Australian Register of Therapeutic Goods (ARTG), Therapeutic Goods Administration · TGA
- Search, European Medicines Agency
- Semax-Related Bulk Drug Substances: Semax (Free Base) and Semax Acetate
- Symptoms of a stroke
- Селанк® | ЛП-№(010951)-(РГ-RU) | ГРЛС 2026
- POST-COVID SYNDROME, POSSIBILITIES FOR THERAPY OF ASTHENIC DISORDERS WITH SELANK, 2024
- Functional Connectomic Approach to Studying Selank and Semax Effects., Panikratova YR et al. · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2020
Sources checked: 2026-10-18.
Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.